SCHEMBL10310445

SCHEMBL10310445

CCCON1C(C)(C)C2C(C1(C)C)C2(O)N1CCOCC1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10310439 0.89 THRB (0.36) LMNAPOLBSMN1; SMN2
SCHEMBL10310485 0.82 — —
SCHEMBL10310434 0.81 — —
SCHEMBL10310460 0.80 — —
SCHEMBL10310424 0.80 — —
SCHEMBL10310444 0.79 ALDH1A1 (0.34) —
SCHEMBL10310431 0.75 ALDH1A1 (0.31) SMN1; SMN2
SCHEMBL10310422 0.73 CYP2A13 (0.33) SMN1; SMN2
SCHEMBL10310484 0.72 THRB (0.33) LMNAPOLBSMN1; SMN2
SCHEMBL10310450 0.71 THRB (0.33) LMNAPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2805938-A1 Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation BASF SE (DE) 2014-11-26 — — EP disclosed
US-8809533-B2 Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation BASF SE (DE) 2014-08-19 — — US disclosed
US-8809533-B2 Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation BASF SE (DE) 2014-08-19 — — US disclosed
EP-2464628-B1 BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION BASF SE (DE) 2014-07-23 — — EP disclosed
US-20140039100-A1 BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION BASF SE (DE) 2014-02-06 — — US disclosed
US-20140039100-A1 BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION BASF SE (DE) 2014-02-06 — — US disclosed
US-20120178829-A1 BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION BASF SE (DE) 2012-07-12 — — US disclosed
US-20120178829-A1 BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION BASF SE (DE) 2012-07-12 — — US disclosed
WO-2011018384-A1 BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION BASF SE (DE) 2011-02-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178829-A1 BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION CAT, SCO2, GPX4 LMNA 1051/4885POLB 191/4885SMN1; SMN2 2616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback